In contrast to concerns of lean mass loss with GLP-1 receptor agonists, a large population-based study found lower fracture rates with semaglutide than with other weight-loss medications.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/semaglutide-linked-lower-fracture-risk-than-other-weight-2026a1000kbs?src=rss
Author :
Publish date : 2026-06-16 16:31:00
Copyright for syndicated content belongs to the linked Source.
